NORTH CHICAGO, Illinois, February 17, 2017 /PRNewswire/ --
Feb. 17, 2017 -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.
The cash dividend is payable May 15, 2017 to stockholders of record at the close of business on April 13, 2017.
Since the company's inception in 2013, AbbVie has increased its dividend by 60 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs approximately 30,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
CONTACT: Media: Adelle Infante, (847) 938-8745 or Investors: Liz Shea, (847) 935-2211
This is a disclosure announcement from PR Newswire.
SOURCE AbbVie, Inc.